open access publication

Article, 2024

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Leukemia, ISSN 1476-5551, 0887-6924, Volume 38, 4, Page 925, 10.1038/s41375-024-02184-z

Contributors

Flygt, Hjalmar 0000-0002-8912-2324 (Corresponding author) [1] Söderlund, Stina [1] Richter, Johan 0000-0002-0374-6823 [2] Saussele, Susanne 0000-0003-0357-5785 [3] Koskenvesa, Perttu 0000-0002-7121-321X [4] Stenke, Leif Å L [5] Mustjoki, Satu Maarit 0000-0002-0816-8241 [4] [6] [7] Dimitrijevic, Andreja [8] Stentoft, Jesper 0009-0003-4969-1201 [9] Majeed, Waleed [10] Roy, Lydia [11] Wolf, Dominik Georg Friedrich 0000-0002-4761-075X [12] [13] Dreimane, Arta [14] Gjertsen, Bjørn Tore 0000-0001-9358-9704 [15] Gedde-Dahl, Tobias J 0000-0002-3037-5378 [16] Ahlstrand, Erik 0000-0003-1928-7518 [17] Markevärn, Berit [18] Hjorth-Hansen, Henrik [19] Janssen, Jeroen J W M Jwm 0000-0001-9567-1955 [20] Olsson-Strömberg, Ulla [1]

Affiliations

  1. [1] Uppsala University Hospital
  2. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  3. [2] Skåne University Hospital
  4. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  5. [3] Heidelberg University
  6. [NORA names: Germany; Europe, EU; OECD];
  7. [4] Helsinki University Hospital
  8. [NORA names: Finland; Europe, EU; Nordic; OECD];
  9. [5] Karolinska Institutet
  10. [NORA names: Sweden; Europe, EU; Nordic; OECD];

Keywords

TKI, attempt, dasatinib, discontinuation attempt, interim results, patients, remission, results, treatment-free remission, trials

Data Provider: Digital Science